MCM
CYRX icon

Marathon Capital Management’s CryoPort CYRX Stock Holding History

Marathon Capital Management’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$474K Sell
57,225
-30,000
-34% -$271K 0.11% 107
2025
Q4 		$837K Sell
87,225
-22,775
-21% -$215K 0.18% 82
2025
Q3 		$1.04M Sell
110,000
-11,725
-10% -$98.7K 0.24% 70
2025
Q2 		$908K Buy
121,725
+33,045
+37% +$205K 0.23% 70
2025
Q1 		$539K Sell
88,680
-2,050
-2% -$14.2K 0.14% 87
2024
Q4 		$706K Sell
90,730
-49,730
-35% -$371K 0.18% 78
2024
Q3 		$1.14M Sell
140,460
-7,825
-5% -$64K 0.28% 65
2024
Q2 		$1.02M Sell
148,285
-4,700
-3% -$63.3K 0.26% 68
2024
Q1 		$2.71M Sell
152,985
-500
-0.3% -$7.92K 0.65% 40
2023
Q4 		$2.38M Sell
153,485
-23,315
-13% -$305K 0.6% 45
2023
Q3 		$2.42M Buy
176,800
+118,090
+201% +$1.74M 0.61% 46
2023
Q2 		$1.01M Sell
58,710
-11,665
-17% -$239K 0.25% 69
2023
Q1 		$1.69M Buy
70,375
+15,200
+28% +$331K 0.42% 58
2022
Q4 		$957K Buy
55,175
+20,475
+59% +$432K 0.26% 67
2022
Q3 		$845K Buy
34,700
+720
+2% +$24.8K 0.24% 73
2022
Q2 		$1.05M Buy
33,980
+2,100
+7% +$55.9K 0.34% 59
2022
Q1 		$1.11M Buy
31,880
+100
+0.3% +$3.78K 0.32% 57
2021
Q4 		$1.88M Sell
31,780
-2,600
-8% -$180K 0.44% 46
2021
Q3 		$2.29M Sell
34,380
-2,125
-6% -$131K 0.52% 41
2021
Q2 		$2.3M Buy
36,505
+150
+0.4% +$8.44K 0.53% 39
2021
Q1 		$1.89M Sell
36,355
-3,345
-8% -$203K 0.5% 38
2020
Q4 		$1.74M Sell
39,700
-7,150
-15% -$341K 0.51% 42
2020
Q3 		$2.22M Sell
46,850
-5,900
-11% -$239K 0.81% 24
2020
Q2 		$1.6M Sell
52,750
-12,600
-19% -$280K 0.61% 29
2020
Q1 		$1.11M Buy
65,350
+400
+0.6% +$7.01K 0.51% 34
2019
Q4 		$1.07M Buy
+64,950
New +$966K 0.36% 50

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Marathon Capital Management's CYRX Position: Q1 2026 in Review

Marathon Capital Management reduced its CryoPort (CYRX) stake by 34% in Q1 2026, selling an estimated $271K and leaving 57,225 shares worth $474K. The position accounts for 0.11% of the portfolio, ranked #107.

Marathon Capital Management first reported a position in CYRX in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.71M in Q1 2024. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • Marathon Capital Management held 57,225 shares of CryoPort worth $474K as of Q1 2026.
  • Marathon Capital Management sold 30,000 CryoPort shares in Q1 2026, an estimated $271K.
  • CryoPort made up 0.11% of Marathon Capital Management's portfolio in Q1 2026, its #107 holding.
  • Marathon Capital Management first reported a position in CryoPort in Q4 2019 and has held it in 26 quarters since.
  • Marathon Capital Management's CryoPort position peaked at $2.71M in Q1 2024.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Marathon Capital Management's 13F filing for Q1 2026, filed 14 May 2026.